Suchergebnisse - (Person:"Rizk, John G")

PubPharm (6)

1

FDA's dilemma with the aducanumab approval : public pressure and hope, surrogate markers and efficacy, and possible next steps

enthalten in: BMJ evidence-based medicine | 2023

von Rizk, J. | Lewin, J.

2

To Anticoagulate or Not to Anticoagulate in COVID-19 : Lessons after 2 Years

enthalten in: Seminars in thrombosis and hemostasis | 2023

von Rizk, J. | Gupta, A. | Lazo, J. | +4

3

Proposal for a Simple Algorithmic Approach to Manage Drug-Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients

enthalten in: Seminars in thrombosis and hemostasis | 2023

von Rizk, J. | Lazo, J. | Gupta, A. | +2

4

Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients

enthalten in: Seminars in thrombosis and hemostasis | 2023

von Rizk, J. | Lavie, C. | Henry, B.

5

Triglycerides and Renal Outcomes According to Albuminuria and in Consideration of Other Metabolic Syndrome Components in Diabetic US Veterans

enthalten in: American journal of nephrology | 2023

von Rizk, J. | Hsiung, J. | Arif, Y. | +5

6

Serum Creatinine-to-Cystatin-C Ratio as a Potential Muscle Mass Surrogate and Racial Differences in Mortality

enthalten in: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation | 2023

von Rizk, J. | Streja, E. | Wenziger, C. | +4

1
[1]